US · NPB
Northpointe Bancshares, Inc.
- Sector
- Financial Services · Banks - Regional
- Headquarters
- Grand Rapids, MI 49546-1467
- Website
- northpointe.com
Price · as of 2024-12-31
$17.83
Market cap 269.84M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $61.11 | +242.74% |
| Intrinsic Value(DCF) | $528.49 | +2,864.05% |
| Graham-Dodd Method(GD) | $105.27 | +490.42% |
| Graham Formula(GF) | $57.65 | +223.34% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $12.19 | $142.23 | |||
| 2022 | $174.45 | $22,144.42 | |||
| 2023 | $114.20 | $43.95 | |||
| 2024 | $13.92 | $61.11 | $461.66 | $105.27 | $57.65 |
AI valuation
Our deep-learning model estimates Northpointe Bancshares, Inc.'s (NPB) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $61.11
- Current price
- $17.83
- AI upside
- +242.74%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$528.49
+2,864.05% upside
Graham-Dodd
$105.27
+490.42% upside
Graham Formula
$57.65
+223.34% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| NPB | Northpointe Bancshares, I… | $17.83 | 269.84M | +243% | +2,864% | +490% | +223% | 3.76 | 0.14 | 0.53 | -13.43 | 3.94 | 0.14 | 48.01% | 18.66% | 14.13% | 3.46% | -54.70% | 2.65% | 0.02 | 0.36 | 20.90 | 20.51 | -6.13 | 9565.00% | 773.00% | -16969.00% | 9.03% | 0.32 | -18.60% | 5.58% | 21.00% | 11.52% | -14.13 | -54.89 | -2.64 | -5.63 |
| ALXO | ALX Oncology Holdings Inc… | $2.11 | 114.42M | — | — | — | — | -0.41 | 0.49 | — | 0.42 | — | 0.49 | 0.00% | — | — | -88.91% | -1054.84% | -69.10% | 0.15 | -82.40 | 7.26 | 6.95 | 0.00 | -3102.00% | — | -705.00% | -221.24% | -6.59 | -905.96% | 0.00% | 0.00% | 0.00% | 0.39 | 0.45 | — | -7.15 |
| BNR | Burning Rock Biotech Limi… | $25.83 | 27.81M | -70% | -90% | — | — | -1.20 | 0.72 | 0.81 | 0.19 | — | 0.72 | 70.26% | -69.32% | -67.20% | -51.38% | -256.37% | -36.01% | 0.09 | — | 2.92 | 2.60 | 1.73 | -4726.00% | -402.00% | -6295.00% | -23.64% | -0.35 | -70.44% | 0.00% | 0.00% | 0.02% | 0.15 | 0.53 | -0.10 | -5.88 |
| CCCC | C4 Therapeutics, Inc. | $2.70 | 192.18M | +704% | -21% | — | — | -2.50 | 1.02 | 7.31 | -0.72 | — | 1.02 | 77.81% | -290.68% | -292.08% | -44.44% | -199.27% | -29.63% | 0.23 | — | 7.81 | 7.60 | 0.14 | -1645.00% | 102.00% | 5198.00% | -37.79% | -2.99 | -189.38% | 0.00% | 0.00% | 9.54% | -0.71 | -0.75 | 2.06 | -1.45 |
| CGEM | Cullinan Therapeutics, In… | $15.50 | 915.68M | — | — | — | — | -2.79 | 0.79 | — | -0.43 | — | 0.79 | 0.00% | — | — | -32.10% | -214.36% | -30.30% | 0.00 | — | 13.53 | 13.12 | 0.48 | -1572.00% | — | 805.00% | -31.02% | -4.74 | -158.17% | 0.00% | 0.00% | 0.00% | -0.36 | -0.49 | — | 7.79 |
| ERAS | Erasca, Inc. | $13.66 | 4.23B | — | — | — | — | -2.21 | 0.84 | — | -0.73 | — | 0.84 | 0.00% | — | — | -43.68% | -151.38% | -36.01% | 0.12 | — | 9.84 | 9.58 | 0.10 | -1687.00% | — | 2814.00% | -36.89% | -3.49 | -111.24% | 0.00% | 0.00% | 0.00% | -0.62 | -0.84 | — | 0.06 |
| LEGN | Legend Biotech Corporatio… | $19.00 | 1.75B | +139% | +396,718% | -91% | — | -20.39 | 3.10 | 5.14 | -21.66 | — | 3.72 | 62.60% | -48.35% | -28.22% | -13.80% | -112.36% | -8.99% | 0.34 | -14.03 | 4.62 | 4.49 | -0.56 | -6701.00% | 11997.00% | -6199.00% | -4.91% | -0.52 | -58.59% | 0.00% | 0.00% | 0.00% | -8.08 | -15.50 | 3.91 | 2.18 |
| ZLAB | Zai Lab Limited | $19.22 | 2.13B | +50% | -49% | — | — | -11.49 | 2.82 | 4.38 | -9.81 | — | 3.16 | 58.60% | -49.86% | -38.15% | -22.56% | -97.09% | -14.89% | 0.31 | -44.05 | 2.45 | 1.91 | 2.88 | -3846.00% | 1533.00% | -4251.00% | -7.88% | -0.36 | -68.36% | 0.00% | 0.00% | 7.89% | -6.77 | -9.77 | 3.37 | -0.13 |
About Northpointe Bancshares, Inc.
Northpointe Bancshares, Inc. operates as the bank holding company for Northpointe Bank provides various banking products and services in the United States. It operates through two segments: Mortgage Purchase Program and Retail Banking. The company offers digital deposit banking, such as noninterest-bearing accounts, savings, money-market demand accounts, and certificates of deposits; personal and business banking; and health saving accounts; home loans; mortgage purchase program; residential mortgage lending; and custodial deposit services. Northpointe Bancshares, Inc. was incorporated in 1998 and is headquartered in Grand Rapids, Michigan.
- CEO
- Charles A. Williams
- Employees
- 491
- Beta
- -0.05
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($528.49 ÷ $17.83) − 1 = +2,864.05% (DCF, example).